Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel safe synthesis of Mupirovir using solid hydroxylamine salts. High purity >99.8%, scalable process, cost-effective manufacturing for global supply chains.
Patent CN107722068A reveals high-efficiency iridium catalysts for chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and supply chain advantages.
Patent CN107540656B reveals a high-yield ester-solvent route for Alogliptin Benzoate, offering superior purity and safety for pharmaceutical manufacturing.
Patent CN117384226B details a high-purity GalNAc synthesis route offering significant cost reduction and supply chain reliability for oligonucleotide drug manufacturing.
Patent CN104292157A reveals efficient route. Reduces costs and improves supply chain reliability for global pharmaceutical intermediate manufacturing partners significantly.
Patent CN114671849A discloses a mild ring-opening method for pyranose rings, offering high yields and environmental benefits for reliable pharmaceutical intermediate supply chains.
Advanced synthesis of 5-trifluoromethyl-2'-deoxyuridine via patent CN100334100C. Offers cost reduction in antiviral agent manufacturing and high-purity pharmaceutical intermediates supply.
Patent CN101575354B reveals a high-yield route for Dibekacin. Discover cost-effective Arbekacin intermediate manufacturing with reduced heavy metal waste.
Analyze patent CN103833570B for Oseltamivir synthesis. Discover a 5-step route with 40% yield, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110563605B reveals a novel PTC-catalyzed route for Etazocine intermediates, offering superior chiral purity and scalable manufacturing for global pharmaceutical supply chains.
Novel route for Imrecoxib via dihydrofuranone intermediate. Eliminates chromium toxicity, reduces cost, and ensures supply continuity for API manufacturing.
Improved GalNAc ribose ring preparation method enhances yield and purity. Reliable supplier for scalable oligonucleotide intermediate manufacturing with cost reduction.
Patent CN101481381B introduces a green aqueous method for Ciprofloxacin production using Lewis acid catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel olefin metathesis route for Voclosporin intermediates ensures high purity and scalable manufacturing for pharmaceutical supply chains globally and efficiently today.
Novel patent CN107245089A offers cost-effective Obeticholic Acid synthesis. Enhanced supply chain reliability and scalable manufacturing for global pharmaceutical partners.
Novel estrone-based route using dimethyl carbonate replaces toxic methylating agents, offering high yield and cost reduction for pharmaceutical intermediates.
Patent CN101314042B reveals a microwave-catalyzed synthesis for water-soluble 4'-demethylpodophyllotoxin derivatives, offering high yields and streamlined manufacturing for pharmaceutical intermediates.
Novel synthesis method for LND1035 ADC intermediate. High yield, scalable process. Reliable supplier for antibody drug conjugate manufacturing.
Novel 3-step route for Procaterol Impurity I from patent CN112645875A. High yield, scalable process for API quality control and reference standards.
Patent CN102260255B reveals a cost-effective two-step synthesis for 9,10-dimethoxy-3-isobutyl-benzo[a]quinolizidine-2-one using water media, offering significant supply chain advantages.